DE69230221D1 - Verfahren für die in-vitro-diagnose von mit charcot-marie-tooth-krankheit vom typ-1a zusammenhängenden chromosomenanomalien - Google Patents

Verfahren für die in-vitro-diagnose von mit charcot-marie-tooth-krankheit vom typ-1a zusammenhängenden chromosomenanomalien

Info

Publication number
DE69230221D1
DE69230221D1 DE69230221T DE69230221T DE69230221D1 DE 69230221 D1 DE69230221 D1 DE 69230221D1 DE 69230221 T DE69230221 T DE 69230221T DE 69230221 T DE69230221 T DE 69230221T DE 69230221 D1 DE69230221 D1 DE 69230221D1
Authority
DE
Germany
Prior art keywords
probes
vitro diagnosis
disease
charcot
marie
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69230221T
Other languages
English (en)
Other versions
DE69230221T2 (de
Inventor
Broeckhoven Christine Neur Van
Peter Neurog Lab B Raeymaekers
Jonghe Peter De
Jean-Jacques Neuropat L Martin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujirebio Europe NV SA
Original Assignee
Innogenetics NV SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innogenetics NV SA filed Critical Innogenetics NV SA
Application granted granted Critical
Publication of DE69230221D1 publication Critical patent/DE69230221D1/de
Publication of DE69230221T2 publication Critical patent/DE69230221T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
DE69230221T 1991-05-07 1992-05-06 Verfahren für die in-vitro-diagnose von mit charcot-marie-tooth-krankheit vom typ-1a zusammenhängenden chromosomenanomalien Expired - Fee Related DE69230221T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP91401220A EP0512181A1 (de) 1991-05-07 1991-05-07 Verfahren zum in vitro Nachweis von Chromosomenanomalien, korrelierend mit der CMT1A-Krankheit
PCT/EP1992/001026 WO1992019770A2 (en) 1991-05-07 1992-05-06 Process for the in vitro diagnosis of chromosomal anomalies correlated with cmt1a disease

Publications (2)

Publication Number Publication Date
DE69230221D1 true DE69230221D1 (de) 1999-12-02
DE69230221T2 DE69230221T2 (de) 2000-05-31

Family

ID=8208565

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69230221T Expired - Fee Related DE69230221T2 (de) 1991-05-07 1992-05-06 Verfahren für die in-vitro-diagnose von mit charcot-marie-tooth-krankheit vom typ-1a zusammenhängenden chromosomenanomalien

Country Status (10)

Country Link
US (1) US6110670A (de)
EP (2) EP0512181A1 (de)
AT (1) ATE186074T1 (de)
AU (1) AU1683192A (de)
CA (1) CA2102300A1 (de)
DE (1) DE69230221T2 (de)
DK (1) DK0584145T3 (de)
ES (1) ES2139596T3 (de)
GR (1) GR3032235T3 (de)
WO (1) WO1992019770A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6225057B1 (en) * 1998-07-23 2001-05-01 Palleja, Zavier Estivell Duplications of human chromosome 15q24-25 and anxiety disorders, diagnostic methods for their detection
FR2808276B1 (fr) * 2000-04-26 2004-04-02 Renaud Nalin Procede d'extraction indirecte de l'adn d'organismes non cultivables et adn susceptible d'etre obtenu par ledit procede
WO2002051981A2 (en) 2000-12-13 2002-07-04 Baylor College Of Medecine Defects in periaxin associated with myelinopathies
US9186685B2 (en) 2012-01-13 2015-11-17 The University Of British Columbia Multiple arm apparatus and methods for separation of particles
US8133371B2 (en) * 2004-02-02 2012-03-13 The University Of British Columbia Scodaphoresis and methods and apparatus for moving and concentrating particles
US8529744B2 (en) 2004-02-02 2013-09-10 Boreal Genomics Corp. Enrichment of nucleic acid targets
US10337054B2 (en) 2004-02-02 2019-07-02 Quantum-Si Incorporated Enrichment of nucleic acid targets
KR100613038B1 (ko) 2004-07-07 2006-08-16 공주대학교 산학협력단 염색체 17ｐ11.2-ｐ12 지역의 중복을 제외한 유전자돌연변이를 발병 원인으로 하는 ＣＭＴ 질환의 진단방법및 진단키트
KR100642421B1 (ko) * 2004-07-07 2006-11-03 공주대학교 산학협력단 염색체 17ｐ11.2-ｐ12 지역의 중복 및 결실로 발병하는유전성 신경질환의 진단방법 및 진단키트
CA2496294A1 (en) 2005-02-07 2006-08-07 The University Of British Columbia Apparatus and methods for concentrating and separating particles such as molecules
WO2009094772A1 (en) 2008-02-01 2009-08-06 The University Of British Columbia Methods and apparatus for particle introduction and recovery
US8877028B2 (en) 2009-04-21 2014-11-04 The University Of British Columbia System and methods for detection of particles
CA2742327A1 (en) 2011-05-20 2012-11-20 The University Of British Columiba Systems and methods for enhanced scoda
WO2013166444A2 (en) 2012-05-04 2013-11-07 Boreal Genomics Corp. Biomarker analysis using scodaphoresis
US9340835B2 (en) 2013-03-15 2016-05-17 Boreal Genomics Corp. Method for separating homoduplexed and heteroduplexed nucleic acids
US11130986B2 (en) 2015-05-20 2021-09-28 Quantum-Si Incorporated Method for isolating target nucleic acid using heteroduplex binding proteins
MX2022005183A (es) 2019-10-29 2022-08-08 Quantum Si Inc Bombeo peristáltico de fluidos y métodos, sistemas y dispositivos asociados.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5306616A (en) * 1991-06-06 1994-04-26 Baylor College Of Medicine Molecular diagnosis of autosomal dominant charcot-marie-tooth disease
WO1992021694A1 (en) * 1991-06-06 1992-12-10 Baylor College Of Medicine Molecular diagnosis of autosomal dominant charcot-marie-tooth disease

Also Published As

Publication number Publication date
ATE186074T1 (de) 1999-11-15
CA2102300A1 (en) 1992-11-08
AU1683192A (en) 1992-12-21
DK0584145T3 (da) 2000-04-25
ES2139596T3 (es) 2000-02-16
WO1992019770A2 (en) 1992-11-12
DE69230221T2 (de) 2000-05-31
EP0512181A1 (de) 1992-11-11
EP0584145B1 (de) 1999-10-27
WO1992019770A3 (en) 1993-01-07
EP0584145A1 (de) 1994-03-02
GR3032235T3 (en) 2000-04-27
US6110670A (en) 2000-08-29

Similar Documents

Publication Publication Date Title
DE69230221D1 (de) Verfahren für die in-vitro-diagnose von mit charcot-marie-tooth-krankheit vom typ-1a zusammenhängenden chromosomenanomalien
Amler et al. Amplified N-myc in human neuroblastoma cells is often arranged as clustered tandem repeats of differently recombined DNA
DE3834636C2 (de)
Desmaze et al. Routine diagnosis of DiGeorge syndrome by fluorescent in situ hybridization
Pearson The use of new staining techniques for human chromosome identification.
EP1589028A3 (de) Modifizierte Oligonukleotide, deren Herstellung sowie deren Verwendung
DE69230177D1 (de) Verfahren und gerät zur automatischen bestimmung von gewebe
ATE333517T1 (de) Verfahren und sondenset zur erkennung von krebs
DE58908694D1 (de) Oligonucleotidbank und verfahren zur dna-sequenzierung.
Drumheller et al. Precise localisation of 3p25 breakpoints in four patients with the 3p-syndrome.
schiamady et al. Premature chromosome condensation after in-vitro fertilization
ATE181422T1 (de) Verfahren zur diagnose von praeklampsie
Smith et al. Molecular genetic delineation of a deletion of chromosome 13q12→ q13 in a patient with autism and auditory processing deficits
Lin et al. A suggestion for the nomenclature of the fluorescent banding patterns in human metaphase chromosomes
DE69705936D1 (de) Teil der intronsequenz des von hippel-lindau(vhl)-gens und seine verwendung zur krankheitsdiagnose
ATE261497T1 (de) Diagnostisches verfahren und gerät
DE69022362D1 (de) Nukleinsäuresonden für die detektion von neisseria gonorrhoeae.
Simard et al. Linkage study of chronic childhood-onset spinal muscular atrophy (SMA): confirmation of close linkage to D5S39 in French Canadian families
Jacob et al. Acceleration of axonal outgrowth in motor axons from mature and old F344 rats after a conditioning lesion
Roses et al. Recombinant DNA strategies in genetic neurological diseases
SULKAVA et al. No elevated sister chromatid exchange in Alzheimer's disease
Millán et al. An autosomal dominant retinitis pigmentosa family with close linkage to D7S480 on 7q
Warren Trinucleotide repetition and fragile X syndrome
Hug et al. Physical mapping of the uterine leiomyoma t (12; 14)(q13‐15; q24. 1) breakpoint on chromosome 14 between SPTB and D14S77
Sinnett et al. Determination of DNA replication kinetics in synchronized human cells using a PCR-based assay

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee